{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:57Z","timestamp":1793608017694,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI143710"],"award-info":[{"award-number":["R01AI143710"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR002244"],"award-info":[{"award-number":["TL1 TR002244"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002243"],"award-info":[{"award-number":["UL1 TR002243"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129128","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:00:43Z","timestamp":1788472843000},"page":"129128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States"],"prefix":"10.1016","volume":"92","author":[{"given":"Hui","family":"Nian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rees L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebeb","family":"Gebretsadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon C.","family":"Enujioke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison B.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Sengstack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne A.","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina V.","family":"Hartert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129128_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100769","article-title":"Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the trisomy 21 research society and the UK ISARIC4C survey","volume":"33","author":"Huls","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2026.129128_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1219","article-title":"COVID-19 in patients with Down syndrome: a systematic review","volume":"12","author":"Pitchan Velammal","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.vaccine.2026.129128_bb0015","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1126\/science.370.6523.1384","article-title":"People with Down syndrome face high risk from coronavirus","volume":"370","author":"Wadman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.129128_bb0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/M20-4986","article-title":"COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults","volume":"174","author":"Clift","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vaccine.2026.129128_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10215125","article-title":"COVID-19 in children with Down syndrome: data from the Trisomy 21 Research Society survey","volume":"10","author":"Emes","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vaccine.2026.129128_bb0030","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10072-021-05091-8","article-title":"COVID-19 in patients with Down syndrome","volume":"42","author":"Emami","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.vaccine.2026.129128_bb0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-3016.2000.00252.x","article-title":"Survival of infants born with Down\u2019s syndrome: 1980-96","volume":"14","author":"Leonard","year":"2000","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"10.1016\/j.vaccine.2026.129128_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fpubh.2014.00022","article-title":"Hospitalization of children with Down syndrome","volume":"2","author":"Tenenbaum","year":"2014","journal-title":"Front. Public Health"},{"key":"10.1016\/j.vaccine.2026.129128_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2027160","article-title":"The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review","volume":"18","author":"Mohammed","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.vaccine.2026.129128_bb0050","author":"Centers for disease control and prevention"},{"key":"10.1016\/j.vaccine.2026.129128_bb0055","author":"Centers for disease control and prevention"},{"key":"10.1016\/j.vaccine.2026.129128_bb0060","article-title":"Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: an integrative review","volume":"142","author":"Silva","year":"2023","journal-title":"Sao Paulo Med. J."},{"key":"10.1016\/j.vaccine.2026.129128_bb0065","article-title":"COVID-19 vaccination of individuals with Down syndrome\u2014data from the trisomy 21 research society survey on safety, efficacy, and factors associated with the decision to be vaccinated","volume":"10","author":"Huls","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129128_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41581-022-00571-2","article-title":"COVID-19 vaccine hesitancy","volume":"18","author":"Dube","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.vaccine.2026.129128_bb0075","article-title":"Development and validation of a diagnostic algorithm for Down syndrome using birth certificate and International classification of diseases codes","volume":"11","author":"Ammar","year":"2024","journal-title":"Children (Basel)"},{"key":"10.1016\/j.vaccine.2026.129128_bb0080","series-title":"TennIIS: TEnnessee immunization information system","author":"Tennessee department of health","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129128_bb0085","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.15585\/mmwr.mm7038e2","article-title":"Use of Pfizer-BioNTech COVID-19 vaccine in persons aged >\/=16 years: recommendations of the advisory committee on immunization practices - United States, September 2021","volume":"70","author":"Dooling","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0090","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.15585\/mmwr.mm695152e2","article-title":"The advisory committee on immunization practices\u2019 updated interim recommendation for allocation of COVID-19 vaccine - United States, December 2020","volume":"69","author":"Dooling","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0095","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.15585\/mmwr.mm6949e1","article-title":"The advisory committee on immunization practices\u2019 interim recommendation for allocating initial supplies of COVID-19 vaccine - United States, 2020","volume":"69","author":"Dooling","year":"2020","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0100","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.15585\/mmwr.mm7044e2","article-title":"The advisory committee on immunization practices\u2019 interim recommendations for additional primary and booster doses of COVID-19 vaccines - United States, 2021","volume":"70","author":"Mbaeyi","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0105","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.15585\/mmwr.mm6947e3","article-title":"The advisory committee on immunization practices\u2019 ethical principles for allocating initial supplies of COVID-19 vaccine - United States, 2020","volume":"69","author":"McClung","year":"2020","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ajt.16437","article-title":"The advisory committee on immunization practices\u2019 ethical principles for allocating initial supplies of COVID-19 vaccine-United States, 2020","volume":"21","author":"McClung","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.vaccine.2026.129128_bb0115","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.15585\/mmwr.mm695152e1","article-title":"The advisory committee on immunization practices\u2019 interim recommendation for use of Moderna COVID-19 vaccine - United States, December 2020","volume":"69","author":"Oliver","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0120","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The advisory committee on immunization practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.15585\/mmwr.mm7009e4","article-title":"The advisory committee on immunization practices\u2019 interim recommendation for use of Janssen COVID-19 vaccine - United States, February 2021","volume":"70","author":"Oliver","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0130","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2023.07.037","article-title":"A summary of the advisory committee for immunization practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States","volume":"41","author":"Wallace","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129128_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2020-21 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7005a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021-22 influenza season","volume":"70","author":"Grohskopf","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2022-23 influenza season","volume":"71","author":"Grohskopf","year":"2022","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2024-25 influenza season","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0155","series-title":"Victorian health reform: how did the victorians view compulsory vaccination?","author":"The National Archives","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129128_bb0160","first-page":"1","article-title":"Determinants for COVID-19 vaccine hesitancy in the general population: a systematic review of reviews","author":"Kafadar","year":"2022","journal-title":"Z Gesundh Wiss"},{"key":"10.1016\/j.vaccine.2026.129128_bb0165","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3852","article-title":"Parental hesitancy about routine childhood and influenza vaccinations: a national survey","volume":"146","author":"Kempe","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.129128_bb0170","series-title":"Percentage of U.S. population who had been given a COVID-19 vaccination as of April 26, 2023, by state or territory","author":"Statista","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129128_bb0175","series-title":"COVID-19 vaccination demographics in the United States, National","author":"Centers for disease control and prevention","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129128_bb0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.puhe.2024.01.029","article-title":"Child and adolescent COVID-19 vaccination coverage by educational setting","volume":"229","author":"Nguyen","year":"2024","journal-title":"United States Public Health"},{"key":"10.1016\/j.vaccine.2026.129128_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2020.03.025","article-title":"Vaccine hesitancy and low immunization rates in children with Down syndrome","volume":"223","author":"Langkamp","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2026.129128_bb0190","doi-asserted-by":"crossref","first-page":"2232818","DOI":"10.1080\/07853890.2023.2232818","article-title":"Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents","volume":"55","author":"Nguyen","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.vaccine.2026.129128_bb0195","article-title":"COVID-19 vaccine or booster hesitancy among children aged 6 month-5 years, 5-11 years, and 12-17 years in the United States: an analytic cross-sectional study","volume":"36","author":"Park","year":"2023","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1321173","article-title":"Predictors of seasonal influenza and COVID-19 vaccination coverage among adults in Tennessee during the COVID-19 pandemic","volume":"12","author":"Cunningham-Erves","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.vaccine.2026.129128_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pcl.2022.11.003","article-title":"Influenza vaccine hesitancy: scope, influencing factors, and strategic interventions","volume":"70","author":"Stephens","year":"2023","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.vaccine.2026.129128_bb0210","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.15585\/mmwr.mm7050a1","article-title":"Report of health care provider recommendation for COVID-19 vaccination among adults, by recipient COVID-19 vaccination status and attitudes - United States, April-September 2021","volume":"70","author":"Nguyen","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.vaccine.2026.129128_bb0215","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1016\/j.vaccine.2023.11.002","article-title":"COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021","volume":"41","author":"Dudley","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129128_bb0220","series-title":"Modern epidemiology","author":"Rothman","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:37:23Z","timestamp":1793605043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S0264410X26009370"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129128","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129128"}}